sumatriptan has been researched along with Impairment, Light Touch Sensation in 1 studies
Sumatriptan: A serotonin agonist that acts selectively at 5HT1 receptors. It is used in the treatment of MIGRAINE DISORDERS.
sumatriptan : A sulfonamide that consists of N,N-dimethyltryptamine bearing an additional (N-methylsulfamoyl)methyl substituent at position 5. Selective agonist for a vascular 5-HT1 receptor subtype (probably a member of the 5-HT1D family). Used (in the form of its succinate salt) for the acute treatment of migraine with or without aura in adults.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lampl, C | 1 |
| Huber, G | 1 |
| Haas, S | 1 |
| Rittberger, E | 1 |
| Diener, HC | 1 |
1 trial available for sumatriptan and Impairment, Light Touch Sensation
| Article | Year |
|---|---|
Difference in triptan effect in patients with migraine and early allodynia.
Topics: Administration, Intranasal; Administration, Oral; Adolescent; Adult; Face; Female; Humans; Male; Mid | 2008 |